Flash News

E-TJERA

Budget 2025/ Part for health with a reduction in relation to total expenses

Budget 2025/ Part for health with a reduction in relation to total expenses

Year after year, the budget for health is growing at a lower rate than the general budget expenditures, even though the country is facing many needs for services from the aging population and the increase in the burden of diseases.

According to data from the Ministry of Finance, the budget expenditures in 2025 reach 822 billion ALL, about 8.2 billion euros, while the budget for the Ministry of Health is projected to be 80.7 billion ALL, or 9.8 percent of the total expenditures.

This year (2024), the budget of the Ministry of Health is 10.1 percent of the general budget expenditures. In 2021, health expenditures accounted for 10.7% of total expenditures.

In 2025, total expenses from the budget will increase by 6.7%, while expenses for health will increase by 3.6%.

For some other functions the increase in expenditure is twice as much as the increase in general expenditure. For example, the budget of the Ministry of Infrastructure is projected to be 15 percent higher in 2025 compared to 2024, while total budget expenditures increase by 6.7% in 2025.

Thus, wards in the country's hospital centers currently mostly treat mild symptoms of flu and fever, while hundreds of thousands of others suffering from autoimmune diseases and neoplasms are directed to be treated abroad.

The lack of medicines and diagnostic equipment makes the health links in the public sector not work.

The public health system is not meeting the demands of the population, especially with medications. Doctors advise patients with rare diseases to go abroad, as detailed analyzes are not yet done here, and medications for these diseases are not reimbursed. For example, many diagnoses of autoimmune diseases and neoplasms are now treated with innovative therapies and immunotherapies, which are not reimbursement schemes. Medicines for other rare diseases, even when they are reimbursed, are missing, often leaving even children without a cure.

Millions of euros go abroad to treat rare diseases, costing the economy and above all the health of the population. For 10 years, funds in health are often oriented towards non-efficient investments, as the reimbursement of drugs remains stagnant and investments in equipment remain low.

Public hospitals still do not have a "Pet scanner" that identifies diseases in the initial stages, while the University Center of Pristina in Kosovo also has one. For this kind of service, Albanians choose to go abroad at a time when its costs are entirely possible for the financial opportunities that the Albanian state has today./MONITOR

Latest news